Denmark-based pharmaceutical company Lundbeck announced on 10 August that it will cut between 125-175 R&D jobs in Denmark and the United States. The move is part of an “ongoing optimization programme”, the company said in its first half report 2011.
Denmark-based pharmaceutical company Lundbeck announced on 10 August that it will cut between 125-175 R&D jobs in Denmark and the United States. The move is part of an “ongoing optimization programme”, the company said in its first half report 2011.